The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life

June 28, 2021 updated by: Elizabeth Van Tubergen, University of Michigan
The study will compare two different dental materials on dental lesions near the gum line that cause chronic pain on oral health related quality of life.

Study Overview

Status

Terminated

Detailed Description

The study will compare two different dental materials on dental lesions near the gum line. One of the materials is tooth colored and the other material is white but both materials use different mechanisms to attach to the teeth and may have different outcomes. The study will determine if one material is more effective in relieving chronic pain. In addition, we will evaluate changes in oral health related quality of life after the placement of the two different dental materials.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • Dental School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 64 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Males and females age 18-64
  • Chief complaint associated with pain from cold or hot
  • Chronic sensitivity associated with supragingival lesions
  • Pain not associated with decay
  • Fluent in English and able to read English at a 6th grade level
  • Pulpal response <40 via pulp tester
  • Active salivary flow from palpation of parotid and submandibular glands
  • Patients self reporting pain over 6/10 in the past week and/or the past 2 months

Exclusion Criteria:

  • Pregnant women
  • Patients taking benzodiazepines, narcotics and multiple antidepressants for pain management not associated with the oral cavity
  • Unexplained dry mouth
  • Patients taking two or more medications associated with dry mouth
  • Pulpal response >40 via pulp tester
  • Patients requiring treatment for more than 5 decayed sites, periodontal disease and root canal therapy
  • Complicated medical history (>4 concurrent treatment for systemic diseases)
  • Lesion >1mm below the gum line

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: Photac-fil
Participants will have a restoration placed with photac-fil in the lesion near the gum line.
Application of a tooth colored filling in a non-cavitated dental lesion.
Other Names:
  • Resin modified glass ionomer
EXPERIMENTAL: Biodentine
Participants will have a restoration placed with Biodentine in the lesion near the gum line.
Application of a white colored filling in a non-cavitated dental lesion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Global Base Changes of Pain
Time Frame: baseline, week1, week 2, 3 month follow up

A one survey description detailing the changes in pain over time based on the following scale:

  1. -No change (or condition has gotten worse)
  2. -Almost the same, hardly any change at all
  3. -A little better, but no noticeable change
  4. -Somewhat better, but the change has not made any real difference
  5. -Moderately better, and a slight but noticeable change
  6. -Better and a definite improvement that has made a real and worthwhile difference
  7. -A great deal better and a considerable improvement that has made all the difference
baseline, week1, week 2, 3 month follow up
Oral Health Related Quality of Life Using a Survey With 49 Questions
Time Frame: Baseline, week1, week 2, 3 month follow up
A survey of 49 questions to assess oral health related quality of life. The scale measured 49 questions with a yes (1) or no (0) answers with a possible range of 0-49. The more answers of yes will indicate a higher score on the survey, which describes poorer oral health related quality of life. A lower number reflects better oral health related quality of life. A maximum score of 49 is the worst outcome.
Baseline, week1, week 2, 3 month follow up
Brief Pain Inventory
Time Frame: Baseline, week1, week 2, 3 month follow up
6 questions were used to measure pain on a sliding scale from 1-100 at each time point. The scale ranged from 1 being no pain and 100 being extreme pain. The higher the number reflects worse the pain compared to a lower number. The maximum range from the participants was 600 (maximum) and the lowest range of 0 for all questions. The data reflects the averaged sum for each time point for all patients in each arm.
Baseline, week1, week 2, 3 month follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 28, 2017

Primary Completion (ACTUAL)

October 9, 2019

Study Completion (ACTUAL)

October 9, 2019

Study Registration Dates

First Submitted

October 3, 2017

First Submitted That Met QC Criteria

October 5, 2017

First Posted (ACTUAL)

October 6, 2017

Study Record Updates

Last Update Posted (ACTUAL)

July 19, 2021

Last Update Submitted That Met QC Criteria

June 28, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • HUM00111890

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Photac-fil

Subscribe